Cargando…
Insights into novel emerging epigenetic drugs in myeloid malignancies
Epigenetics has been defined as ‘a stably heritable phenotype resulting from changes in a chromosome without alterations in the DNA sequence’ and several epigenetic regulators are recurrently mutated in hematological malignancies. Epigenetic modifications include changes such as DNA methylation, his...
Autores principales: | Chandhok, Namrata S., Prebet, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6685116/ https://www.ncbi.nlm.nih.gov/pubmed/31431820 http://dx.doi.org/10.1177/2040620719866081 |
Ejemplares similares
-
Mutations in Epigenetic Modifiers in Myeloid Malignancies and the Prospect of Novel Epigenetic-Targeted Therapy
por: Fathi, Amir T., et al.
Publicado: (2012) -
The Impact of Epigenetic Modifications in Myeloid Malignancies
por: Venney, Deirdra, et al.
Publicado: (2021) -
Epigenetic therapies: novel strategies for improving outcomes in myeloid malignancies
por: Craddock, Charles
Publicado: (2013) -
Epigenetic Modifiers in Myeloid Malignancies: The Role of Histone Deacetylase Inhibitors
por: Ungerstedt, Johanna S.
Publicado: (2018) -
Epigenetics in Cancer: A Hematological Perspective
por: Stahl, Maximilian, et al.
Publicado: (2016)